Atlas Trials

Kyntra Bio

41 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Kyntra Bio

RecordFirmDate
A Study to Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes (MDS) (NCT07722988)Kyntra Bio2027-04-01
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (NCT06842498)Kyntra Bio2026-02-22
Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD (NCT04621331)Kyntra Bio2022-05-23
Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD (NCT04632940)Kyntra Bio2021-03-03
Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) (NCT04419558)Kyntra Bio2020-09-30
Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD) (NCT04371666)Kyntra Bio2020-08-10
Study of Roxadustat Conversion in Participants Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis Participants (NCT04484857)Kyntra Bio2020-07-22
Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 Disease (NCT04432298)Kyntra Bio2020-06-20
Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as Initial Anemia Treatment in Chronic Dialysis Participants (NCT04410198)Kyntra Bio2020-05-26
Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia (NCT04076943)Kyntra Bio2019-08-20
Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) (NCT03955146)Kyntra Bio2019-06-18
Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney Disease (NCT04059913)Kyntra Bio2019-06-11
Efficacy and Safety of FG-4592 for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome (MDS) (NCT03303066)Kyntra Bio2018-06-06
Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden (NCT03263091)Kyntra Bio2018-01-29

Track Kyntra Bio automatically

Every clearance here is in the API, with alerts when new ones post.